Diagnos, a corporation based in Brossard, Quebec, has signed a letter of intent with an Indian partner for the deployment of its tele-ophthalmology platform, CARA, in India.

 

The Computer Assisted Retinal Analysis (CARA) platform integrates with ophthalmic imaging hardware and software. CARA enhances retinal images in real time over the Internet.

 

Its partner in India, which for now remains anonymous, wishes to use Diagnos’ technology to slow down or halt the visual deterioration process that occurs in people with diabetes. The International Diabetes Federation estimates the number of diabetics in India to be more than 73 million, and this number could grow to 100 million by 2030. One patient out of nine will suffer from retinopathy and possibly lose their sight.

 

The initial mission would involve deploying mobile screening units, comprising the CARA platform and a qualified vision screening technician, to Mumbai and New Delhi. These units would also cover a radius of 500 km around the respective cities.

 

“The nature of the relationship offers the potential of scaling-up across the vast population and size of India,” said Peter Nowacki, Diagnos’ Vice-President – Healthcare. “We believe the lower cost dynamics in India coupled with a large volume potential across the country to be strong drivers of value for Diagnos shareholders.”

Source:

http://www.directioninformatique.com/une-plateforme-de-teleophtalmologie-quebecoise-en-inde/21316

 

 

 

Techniques developed by astronomers are coming closer to optometry and ophthalmology.

 

Historically, optometrists and ophthalmologists have focussed largely on two vision problems: spherical errors and astigmatism. However, a variety of other subtle errors can affect both the clarity of a patient’s vision and the ECP’s view when examining the back of the eye.

 

Techniques developed by astronomers to better distinguish objects in space can help identify these errors. This is particularly the case with wavefront optics, says Dr. Larry N. Thibos, from Indiana University, in a recent paper published in Optometry and Vision Science. In a wavefront, all the points of the surface take the same amount of time to travel the distance from the source. It can therefore be observed to analyze light propagation.

 

For Dr. Thibos, this concept transforms the way fundamental optical problems are approached. He gives examples of how it could be used, such as monitoring changes in optical quality in eyes with deterioration of the tear film, assessing the outcomes of vision-correcting therapies, and tracking the progression of visual abnormalities in growing eyes.

Sources:

http://www.medicalnewstoday.com/releases/265320.php

http://journals.lww.com/optvissci/Fulltext/2013/09000/The_2012_Charles_Prentice_Medal_Lecture__.4.aspx

 

 

In Africa, UK researchers are currently testing a set of eye tests based on a smartphone, which could radically change eye health in poorer countries.

 

Performing eye health tests at an ophthalmologist’s office requires expensive hospital equipment and specialized staff. In many places around the world, that creates an insurmountable barrier for patients. According to the World Health Organization, nine out of ten blind people live in poor nations.

 

The PEEK (Portable Eye Examination Kit) is made up of a mobile app and clip-on hardware that transform a smartphone into a portable eye clinic. It can be operated by a non-expert to gather detailed clinical information, diagnose cataracts, prescribe lenses and even check the retina for signs of disease, such as brain cancer or cerebral hemorrhage. The PEEK system stores information about patients together with their GPS location.

 

The researchers are presently testing the system in Nakaru, Kenya. They start by performing tests with PEEK then repeat the tests with the traditional system to compare diagnoses. Over 1,000 people have already received one form of treatment or another.

 

This type of device has great potential for Canada, namely in the northern regions.

Source:

www.medicalnewstoday.com/articles/264905.php

 

Researchers in Taiwan have discovered that people with sleep apnea are far more likely to develop glaucoma compared to those without the sleep condition.

 

Conducted by researchers at Taipei Medical University, the retrospective study involved 1,012 people ages 40 and older who were diagnosed with sleep apnea sometime between 2001 and 2004, as well as 6,072 people without sleep apnea. They found that the people with obstructive sleep apnea had a 1.67 times higher risk of developing open-angle glaucoma in the five years after their initial sleep apnea diagnosis.

 

“We hope that this study encourages clinicians to alert obstructive sleep apnea patients of the associations between obstructive sleep apnea and open-angle glaucoma as a means of raising the issue and encouraging treatment of those who need it,” wrote the authors of the study, published in the journal Ophthalmology.   

 

The Canadian Ophthalmological Society recommends that at-risk patients, especially people with a family history of glaucoma, see an ophthalmologist every three years by age 40, every two years by age 50, and every year after the age of 60. 

 

 

Sources:

www.aao.org/newsroom/release/20130807.cfm

http://www.cos-sco.ca/information-sur-la-sante-visuelle/quand-consulter-un-ophtalmologiste/

 

 

American researchers have published the most thorough description to date of gene expression in the human retina. And it comes with a few surprises.

 

The investigators at Massachusetts Eye and Ear and Harvard Medical School used a technique called RNA sequencing to demonstrate that the majority of the 20,000 genes in the human body are expressed in the retina. This was no real surprise to the scientific community, because the retina is a complex tissue with 60 types of cells.

 

The investigators were quite excited, however, to discover nearly 30,000 new exons and more than 100 potential new genes. Exons are the portions of the genome that are used to encode proteins or other genetic elements. Several thousand of the newly discovered exons appear to be used specifically in the retina.

 

These discoveries will help researchers to better understand how the retina works as well as how it is affected by various diseases, such as inherited degenerations, which result from genetic mutations or errors. While more than 200 genes related to retinal degenerative disease have been identified, scientists have yet to find the cause of disease for up to half of the patients with such disorders. The newly identified exons in the retina may change all that.

Sources:

http://www.sciencedaily.com/releases/2013/07/130718130458.htm  

 

http://www.biomedcentral.com/1471-2164/14/486/abstract